Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
February 2008, Vol 1, No 1
Regulatory
Creating a 21st-Century Intelligent Health System
Newt Gingrich, PhD
,
Nancy Desmond, MEd, EdS
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
Editorial
What Kind of Healthcare Debate Do We Want?
Robert E. Henry
Read More
Editorial
Welcome to our community
Thomas McCarter, MD, FACP
Read More
Regulatory
Medicare Coverage Strategies: Impact of the MMA and PBMs
Stakeholder Perspective
by
Joseph R. Antos, PhD
Read More
Business
Disruptive Innovation: Value-Based Health Plans
F. Randy Vogenberg, PhD, FASHP
Stakeholder Perspective
Value-Based Drug Benefit: Implications for Manufacturers
by
Kip Piper, MA, FACHE
Read More
Business
Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate
Al B. Benson III, MD, FACP, FASCO
,
Elizabeth Brown, MD
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
Clinical
Measuring the Value of Treatment to Patients: Patient-Reported Outcomes in Drug Development
Richard J. Willke, PhD
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
FDA Approvals
Approvable Letters in 2007 and the Outlook for 2008
Mark Senak, JD
Read More
Industry Trends
The 2007 Pharmaceutical and Biotech Pipeline Year-End Summary: What it Says About the State of the Art of Discovery & Development
Michael F. Murphy, MD, PhD
Read More
Results 1 - 9 of 9